Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Behavioral Weight Loss Treatment in Antipsychotic Treated Youth.

Nicol GE, Kolko RP, Mills M, Gunnarsdottir T, Yingling MD, Schweiger JA, Lenze EJ, Newcomer JW, Wilfley D.

Scand J Child Adolesc Psychiatr Psychol. 2016 May;4(2):96-104.

2.

Activating and Tranquilizing Effects of First-Time Treatment with Aripiprazole, Olanzapine, Quetiapine, and Risperidone in Youth.

Al-Dhaher Z, Kapoor S, Saito E, Krakower S, David L, Ake T, Kane JM, Correll CU, Carbon M.

J Child Adolesc Psychopharmacol. 2016 Jun;26(5):458-70. doi: 10.1089/cap.2015.0141. Epub 2016 Apr 19.

PMID:
27093218
3.

Impulsive Aggression as a Comorbidity of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents.

Saylor KE, Amann BH.

J Child Adolesc Psychopharmacol. 2016 Feb;26(1):19-25. doi: 10.1089/cap.2015.0126. Epub 2016 Jan 8.

4.

Adiposity and Cardiometabolic Risk in Children With and Without Antipsychotic Drug Treatment.

Nicol GE, de Las Fuentes L, Riek AE, Bernal-Mizrachi C, Lenze EJ, Miller JP, Schweiger JA, Yingling MD, Huang VJ, Dixon DJ, Hennekens CH, Newcomer JW.

J Clin Endocrinol Metab. 2015 Sep;100(9):3418-26. doi: 10.1210/jc.2015-2119. Epub 2015 Jul 17.

5.

Obesity Prevention for Children with Developmental Disabilities.

Must A, Curtin C, Hubbard K, Sikich L, Bedford J, Bandini L.

Curr Obes Rep. 2014 Jun;3(2):156-70. doi: 10.1007/s13679-014-0098-7.

6.

Managing ADHD and disruptive behaviour disorders with combination psychostimulant and antipsychotic treatment.

Elbe D, Barr AM, Honer WG, Procyshyn RM.

J Psychiatry Neurosci. 2014 May;39(3):E32-3. No abstract available.

7.

Prolactin serum concentrations during aripiprazole treatment in youth.

Safer DJ, Calarge CA, Safer AM.

J Child Adolesc Psychopharmacol. 2013 May;23(4):282-9. doi: 10.1089/cap.2012.0062. Epub 2013 May 6. Review.

8.

Recent advances in understanding and mitigating adipogenic and metabolic effects of antipsychotic drugs.

Gohlke JM, Dhurandhar EJ, Correll CU, Morrato EH, Newcomer JW, Remington G, Nasrallah HA, Crystal S, Nicol G; Adipogenic and Metabolic Effects of APDs Conference Speakers., Allison DB.

Front Psychiatry. 2012 Jun 28;3:62. doi: 10.3389/fpsyt.2012.00062. eCollection 2012.

9.

Correlates of weight gain during long-term risperidone treatment in children and adolescents.

Calarge CA, Nicol G, Xie D, Zimmerman B.

Child Adolesc Psychiatry Ment Health. 2012 May 29;6(1):21. doi: 10.1186/1753-2000-6-21.

10.

The treatment of severe child aggression (TOSCA) study: Design challenges.

Farmer CA, Arnold LE, Bukstein OG, Findling RL, Gadow KD, Li X, Butter EM, Aman MG.

Child Adolesc Psychiatry Ment Health. 2011 Nov 10;5(1):36. doi: 10.1186/1753-2000-5-36.

11.

Hyperprolactinemia with antipsychotic drugs in children and adolescents.

Rosenbloom AL.

Int J Pediatr Endocrinol. 2010;2010. pii: 159402. doi: 10.1155/2010/159402. Epub 2010 Aug 24.

12.

First do no harm: promoting an evidence-based approach to atypical antipsychotic use in children and adolescents.

Panagiotopoulos C, Ronsley R, Elbe D, Davidson J, Smith DH.

J Can Acad Child Adolesc Psychiatry. 2010 May;19(2):124-37.

Supplemental Content

Support Center